Pain care does not have to be a choice between medication and something more hands-on. Massage can belong in the same conversation. The important questions are what kind of massage was studied, who received it, and whether improvement exceeded what happened with another form of care.
Evidence at a glance
Population: selected adults with advanced cancer and persistent musculoskeletal pain. Approach: oncology-adapted massage alongside usual care. Signal: meaningful within-person pain improvement. Limit: the main recent comparison was against acupuncture, not usual care alone. Massage does not treat the underlying cancer.
What IMPACT found
The 2023 IMPACT trial analyzed 298 participants with advanced cancer and moderate-to-severe musculoskeletal pain. Oncology-experienced practitioners delivered 30-minute acupuncture or adapted, light-to-moderate-pressure massage sessions weekly for ten weeks, then monthly through week 26.
Worst pain fell by 3.01 points with massage and 2.53 with acupuncture on a 0–10 scale. The difference between groups was not statistically significant. Without a usual-care-only group, the entire three-point change cannot be attributed to massage itself. Expectations, attention, concurrent treatment, and changes over time may contribute. This was a research schedule, not a universal prescription.
Participants needed an estimated life expectancy of at least six months; those with platelets below 150,000/µL were excluded. Transient soreness occurred in 15.1% receiving massage. These findings may not generalize to more fragile patients.
An older trial helps separate touch from technique
A 2008 randomized trial enrolled 380 adults with advanced cancer and moderate-to-severe pain, most receiving hospice care. It compared six 30-minute massage sessions over two weeks with simple touch. Immediate pain decreased by 1.87 points after massage and 0.97 after touch—an additional reduction of about 0.9 points.
There was no sustained between-group advantage in pain. That does not make a period of comfort worthless. It does change the promise we should make. Brief relief, supportive attention, and durable pain control are different outcomes, and patients deserve to know which one a study actually supports.
Guidelines and the newer review
The 2022 SIO–ASCO pain guideline says massage may be offered for pain during palliative or hospice care. This is an option within a pain plan, not a reason to withhold appropriate analgesia or stop evaluating a new pain.
An umbrella review published March 18, 2026 found encouraging symptom results across 15 reviews. However, 12 were rated low or critically low quality, and the synthesis included related interventions such as reflexology and acupressure. That broad evidence cannot establish that every massage technique produces the same benefit. More reviews do not automatically mean more certainty.
Oncology adaptation is part of safety
NCCIH advises precautions and technique modification for people with cancer; rare serious harms, including fracture or nerve injury, have been reported with massage. A medically informed practitioner should review bone involvement, bleeding risk, recent operations, skin injury, and devices before deciding where and how to work.
Do not massage a suspected clot, an acutely swollen limb, or an unexplained painful area while waiting for a diagnosis. Deep pressure is not inherently more therapeutic. A useful session should fit the person’s comfort and medical situation, with permission to stop at any point.
Questions for the care team
- Is my pain suitable for massage, or does it need further investigation first?
- Can you refer me to a practitioner trained in oncology massage?
- Which areas, pressures, or positions should be avoided?
- How will we judge whether the relief is worth the time and cost while continuing my pain treatment?
Evidence checked October 16, 2026. Educational review; research doses and schedules are not personal prescriptions. Explore the Missing Script article library and the podcast—coming soon.
